Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA’s Label Conversion Project Would Revise Data As Well As Reformat

This article was originally published in The Pink Sheet Daily

Executive Summary

Solicitation asks for contractor to reformat labels to physician labeling rule format, including updates with new information from literature; generic companies like contractor, while brands say it will be resource-intensive for industry and FDA.

You may also be interested in...



FDA’s Drug Labeling Decisions Complicated By Uncertain Target Audience, Limited Authority

Do drug labels try to serve too many masters? With no clear agreement on drug labels’ end user and FDA’s incomplete control of label content, the agency and its Pharmaceutical Science Advisory Committee struggle over how to convey drug-drug interaction information in labeling.

FDA Wants All Drug Manufacturers To Adopt Highlights Labeling Format

Agency is launching an initiative to encourage manufacturers exempt from the final rule to implement the labeling format change anyway; the rule does not apply to drugs approved before June 30, 2001, and only about 10% of brand products have the new format.

Rx Labeling Final Rule Largely In Line With Draft Version

New labeling format will apply initially to recently approved drugs and products receiving approval for new uses, agency says.

Topics

Related Companies

UsernamePublicRestriction

Register

PS076000

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel